Co-Existing ATTR Amyloidosis and Coronary Artery Disease: A Risky Combination

Area of Science:

• Cardiology
• Cardiovascular Imaging
• Amyloidosis Research

Background:

• Cardiac amyloidosis and coronary artery disease (CAD) present a complex clinical challenge.
• Amyloid deposition contributes to arteriosclerosis and intramural microvascular dysfunction.
• Restrictive cardiomyopathy in amyloidosis exacerbates complications during percutaneous coronary intervention (PCI).

Purpose of the Study:

• To highlight the diagnostic complexities of coexisting cardiac amyloidosis and CAD.
• To emphasize the impact of amyloidosis on PCI outcomes.
• To advocate for a multimodal imaging strategy in suspected cardiac amyloidosis.

Main Methods:

• Review of clinical scenarios involving cardiac amyloidosis and CAD.
• Analysis of the pathophysiological interplay between amyloid deposition and vascular disease.
• Discussion of imaging modalities for diagnosing cardiac amyloidosis.

Main Results:

• Amyloid fibril deposition promotes arteriosclerosis and microvascular disease.
• Cardiac amyloidosis significantly increases risks associated with PCI.
• Multimodal imaging aids in the diagnosis of cardiac amyloidosis.

Conclusions:

• The combined presence of cardiac amyloidosis and CAD poses significant clinical and procedural challenges.
• Amyloidosis-related heart failure complicates PCI, necessitating careful patient management.
• A comprehensive, multimodal imaging approach is essential for accurate diagnosis and effective treatment planning.